實驗概要
Lymphocytes are differentiated cells which normally do not undergo subsequent cell divisions. By culturing lymphocytes in the presence of a mitogen (KARYOMAX? Phytohemagglutinin (M-Form) (PHA), Cat. No. 10576), they are stimulated to replicate their DNA and enter into mitosis. After an optimum time of the cells being cultured (46 h for a newborn and 68 h for an adult), a mitotic inhibitor, KARYOMAX COLCEMID? Solution (Cat. No. 15210 or 15212), is added to the lymphocyte culture for 20 min.
The addition of COLCEMID to dividing cells acts to prevent the synthesis of spindle fibers and, therefore, to stop mitosis in metaphase. Metaphase is the optimum phase of mitosis for microscopically visualizing the chromosomes. By submitting cells to a hypotonic solution and a series of fixation steps, metaphase chromosomes can be microscopicallyobserved and analyzed.
As a quality control measure, each lot of Phytohemagglutinin is tested as a chromosome reagent for the examination of metaphase spreads used for cytogenetic studies. This reagent is evaluated by supplementation to an approved, non-phytohemagglutinin containing chromosome medium. These samples are then supplemented with freshly collected human peripheral blood and have been found to be acceptable in their ability to produce blastogenesis with human lymphocytes when compared to a previously tested control.
主要試劑
Phytohemagglutinin (M Form) (PHA), Liquid [Details:Life Technologies Cat# 10576-015]
PB-MAX? Karotyping Medium (1X), Liquid [Details:Life Technologies Cat#12557-013]
KaryoMAX? Colcemid? Solution, Liquid (10 μg/ml), in HBSS [Details:Life Technologies Cat#15210-040]
KaryoMAX? Colcemid? Solution, Liquid (10 μg/ml), in PBS [Details:Life Technologies Cat#15212-012]
實驗步驟
1. The required volume of peripheral blood is collected aseptically in a sodium heparinized vacutainer tube or syringe.
2. Add 10 ml of either PB-MAX Karyotyping Medium or KARYOMAX Peripheral Blood Karyotyping Medium to each sterile T-25 flask to be set up for the assay.
3. Add 0.75ml blood to each tube.
4. Incubate flask in CO2 incubator for 48 to 68 h with caps loose.
5. Add 0.05-0.1 ug/ml COLCEMID to each flask for a 15 minute incubation.
6. After 15 min, transfer flask contents to a 15 ml centrifuge tube and spin down at 1,200 rpm for 5 min.
7. Remove supernatant and resuspend pellet.
8. Add 10 ml of 0.068 M KCl to pellet and gently mix. Allow to sit at room temperature for 15 min. Add 0.5 ml of fixative (three parts absolute methanol to none part glacial acetic acid). Gently mix with pipette.
9. Centrifuge for 5 min at 1,200 rpm. Aspirate off supernatant. Add 10 ml of fixative, mix, and let sit at room temperature for 10 min.
10. Repeat centrifugation step. Add 5 ml of fixative, mix, and let sit for 10 min atroom temperature.
11. Centrifuge and aspirate off supernatant. Add 5 ml of fixative and incubate for 10min at 4°C.
研究闡明了SETD2在調控骨髓增生異常綜合征(MDS)向急性髓系白血病(AML)轉化過程中的作用機制,為MDS臨床治療提供了理論基礎和潛在靶標。MDS是最常見的髓系惡性腫瘤之一,是起源于造血干細胞的一......
為什么有些癌癥治療之后仍會復發?有時候,癌癥的相關治療可以有效地將癌細胞消除到無法檢測的水平,但是,如果停止治療,癌癥可能會復發。例如,在用酪氨酸激酶抑制劑藥物治療慢性粒細胞白血病患者是就會出現停藥后......
化療已使最常見的兒童期癌癥---急性淋巴細胞白血病(ALL)---成為最可治愈的癌癥之一,但是科學家們有證據表明這種治療也可能使某些患者復發。在一項新的研究中,來自中國和美國的研究人員報道由治療引起的......
自然殺傷細胞(Naturalkillercells,NKcells)是一種效應性淋巴細胞,在人體抗腫瘤過程中發揮重要作用,但是,仍然有一些腫瘤細胞能夠逃避機體NK細胞的攻擊,逐步發生發展,侵襲轉移,嚴......
研究人員發現了小鼠體內一種新的轉錄因子可以幫助調節間充質干細胞(mesenchymalstemcells,MSCs)分化為骨的過程。目前科學家們對于骨細胞分化的研究并不深入,而MSCs則是再生醫學領域......
在一項新的研究中,來自美國俄亥俄州大學的DaniloPerrotti和同事證實一種叫做FTY720的藥物能夠抑制由癌癥蛋白BCR-ABL導致的白血病小鼠模型的病情。由于這種藥物還能夠誘導從白血病患者獲......
來自中山大學有害生物控制與資源利用國家重點實驗室(StateKeyLaboratoryofBiocontrol,原生物防治國家重點實驗室),基因工程教育部重點實驗室(KeyLaboratoryofGe......